• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Carbazeran

CAS No. 70724-25-3

Carbazeran ( UK 31557; UK-31557; UK31557; UK 31,557; UK-31,557; UK31,557; )

产品货号. M27410 CAS No. 70724-25-3

Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥988 有现货
10MG ¥1596 有现货
25MG ¥3216 有现货
50MG ¥4771 有现货
100MG ¥6828 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Carbazeran
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
  • 产品描述
    Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
  • 同义词
    UK 31557; UK-31557; UK31557; UK 31,557; UK-31,557; UK31,557;
  • 通路
    Angiogenesis
  • 靶点
    PDE
  • 受体
    ——
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    70724-25-3
  • 分子量
    360.4
  • 分子式
    C18H24N4O4
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CCNC(=O)OC1CCN(CC1)c1nncc2cc(OC)c(OC)cc12
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Jean-Louis H. Dasseux, et al. Ketone compounds and compositions for cholesterol management and related uses. WO2002030860A2.
产品手册
关联产品
  • Ensifentrine

    Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.

  • Oglemilast

    Oglemilast (GRC-3886) is a potent and selective PDE4 inhibitor with IC50 of 2.5 and 1.7 nM for PDE4B and PDE4D, respectively.

  • BAY 2666605

    BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.